What does the future of value-based care look like, and how does technology tie in? A new survey from Quest Diagnostics and Inovalon takes a closer look.
Beginning this summer, Doctor On Demand, a San Francisco, California-based telemedicine startup, will offer laboratory testing services.
Break down the silos. Take control of your provider data.
A new IBM Watson Health and Quest Diagnostics partnership aims to expand access to tumor sequencing and analysis throughout the United States.
The demand has been so strong that consumer genetics company, AncestryDNA, now has a database of two million samples.
A pilot began with just a handful of doctors, but was broadened beyond primary care when it was found to be easy to use and capable of producing valuable information—especially to “downstream” physicians.
The lab giant will provide diagnostic testing services at Quest-branded Patient Services Centers next to the pharmacies at 12 Safeway stores in five states. Presumably, these will occupy spaces originally built for Theranos labs.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
The report lists obvious choices like Quest Diagnostics, LabCorp and 23andMe - and deigns to include even Theranos, despite its recent spate of bad PR.
What pathogen is causing a patient's disease? A coalition of University of California researchers, doctors and Silicon Valley companies are working together to create a test that can diagnose whether a severely ill patient has a virus, bacteria, fungus or parasite.
Doctors will have the ability to order common lab tests such as diabetes screening, cardiovascular risk assessment, hepatitis C screening.
Quest Diagnostics’ (NYSE: DGX) neurology diagnostics division has developed a test to detect amyotrophic lateral sclerosis or Lou Gehrig’s disease. The test is the first of its kind to detect whether the patient has the genetic mutation associated with the disease. The hexanucleotide repeat expansion in the C9orf72 gene is found in up to 39 […]
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Quest Diagnostics (NYSE:DGX), one of the largest diagnostic testing providers, has announced a replacement for its outgoing CEO. Dr. Surya N. Mohapatra will be succeeded by Philips Healthcare CEO Steve Rusckowski effective May 1, according to a company statement. Rusckowski held management positions with the Healthcare Division of Hewlett-Packard/Agilent Technologies and was the general manager […]
A molecular blood test that uses biomarkers to detect renal failure following kidney transplants has been launched by Quest Diagnostics (NYSE:DGX). The test could lower healthcare costs tied to kidney transplant failure. It would help physicians detect kidney failure weeks before other tests or clinical symptoms indicate kidney damage. The test, using technology licensed from […]
Diagnostic testing company Quest Diagnostics (NYSE:DGX) is looking to grow its healthcare IT business following an increase in fourth-quarter revenue and profits partly from acquisitions made last year. The Madison, New Jersey lab testing giant had sales of $1.86 billion with profits of $189.5 million in the fourth quarter. Last year, Quest Diagnostics made two […]
Thanks to new revisions in the Clinical Laboratory Improvement Amendments, patients can use mobile devices to access lab results and other data. A new healthcare app for everything from iPad to Androids delivers automated lab results and educational materials, medication lists, immunization lists, allergy lists, medical contacts and more.
Leading lab company Quest Diagnostics just released the Gazelle app for iPhone and Blackberry, which enables people to see, store, and share their Quest lab results. Quest will provide patients with access to their results 48 hours after releasing them to the ordering physician –at least in the 33 states and DC where it’s legal […]